Ocular Therapeutix (NASDAQ: OCUL) experienced a notable increase in its stock price, rising by 6% as speculation regarding a potential takeover intensified. Traders indicated that a...
New research indicates that male rugby players in New Zealand are at an increased risk of developing neurodegenerative diseases, including Alzheimer’s, compared to the general population....
REGENXBIO, a biotechnology company listed on NASDAQ under the ticker symbol RGNX, has announced promising results from its clinical trial of the gene therapy clemidsogene lanparvovec...
BioNTech SE experienced an approximately 8% increase in its share price during premarket trading on Friday, following the announcement of positive Phase 3 trial results for...
All schools in British Columbia are now mandated to equip themselves with automated external defibrillators (AEDs) and naloxone kits to address heart attacks and drug overdoses....
The Manitoba government is required to submit a new application to Health Canada for a supervised drug consumption site after its initial proposal for a location...
Brad Gordon, a resident of Brandon, Manitoba, is preparing to participate in the Parkinson Canada SuperWalk this Saturday in Winnipeg. Gordon, who was diagnosed with Parkinson’s...
Emblem Cannabis Corporation has initiated a recall of a specific lot of its Divvy Island Rush Infused Pre-Rolls due to significant labelling errors. According to a...
Ontario’s Chief Medical Officer, Dr. Kieran Moore, has called for a national immunization schedule and registry to address the gaps highlighted by the recent resurgence of...
Exelixis, Inc., a biotechnology company focused on cancer therapies, is closing its facility in King of Prussia, Pennsylvania. This decision will lead to the layoff of...
